Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Alexion's Soliris Adds Prescriber Certification In Move From RiskMAP To REMS

Jul 02 2010

• By The Pink Sheet Daily

Related Content

The Downside Of REMS: An Over-Taxed Health Care System – FDA’s Jenkins

Feb 16 2009

FDA Gives Firms With RiskMAP Drugs 6 Months To Submit Strategy Proposals

Mar 26 2008

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window